Author:
Chevaliez Stéphane,Pawlotsky Jean-Michel
Publisher
Springer Berlin Heidelberg
Reference203 articles.
1. (1997) National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26:2S–10S
2. (1999) EASL International Consensus Conference on hepatitis C. Paris, 26–27 February 1999. Consensus statement. J Hepatol 31 Suppl 1:3–8
3. (2002) National Institutes of Health Consensus Development Conference statement: management of hepatitis C: 2002-June 10–12, 2002. Hepatology 36:S3–S20
4. Afdhal NH, O'Brien C, Godofsky E, Rodriguez-Torres M, Pappas SC, Pockros P, Lawitz E, Bzowej N, Rustgi V, Sulkowski M, Sherman KE, Jacobson I, Chao G, Knox S, Pietropaolo K, Brown N (2006) Valopicitabine (NM283), alone or with peg-interferon, compared to peg-interferon/ribavirin (PEGIFN/RBV) retreatment in hepatitis C patients with prior non-response to PEGIFN/RBV: week 24 results. J Hepatol 44 Suppl 2:S19
5. Akarca US, Ersoz G, Gunsar F, Karasu Z, Saritas E, Yuce G, Batur Y (2004) Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B. Antivir Ther 9:325–334
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献